- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Aposense Ltd+ Add to Watchlist
APNSF:US0.2350 USD 0.1450 38.16%
As of 20:10:00 ET on 12/16/2013.
Company Profile for Aposense Ltd (APNSF)
Aposense Limited is a clinical stage molecular imaging and drug development company. The Company has a pipeline of products based on its patented platform technology used for targeting apoptosis. Aposense Ltd targets multiple disease categories including oncology, cardiology, and neurology.
Key Executives for Aposense Ltd (APNSF)
|Alon DumanisChairman||Yoram AsheryChief Executive Officer|
|Dov FarkashChief Financial Officer||Miri Ben-AmiVP:Clinical & Regulation|
|Eli FrydmanVP:Business Development||Menashe LevyVP:Research & Development|
|Tal DavidsonVP:Information||Etty GenisController|